Do analysts rate VHI or CARE?

Vitalhub presently has a consensus price target of C$12.67, suggesting a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher possible upside, equities analysts plainly believe Vitalhub is more favorable than Dialogue Health Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vitalhub 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 Dialogue Health Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts prefer VHI or ADK?

Vitalhub presently has a consensus price target of C$12.67, indicating a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher probable upside, equities research analysts clearly believe Vitalhub is more favorable than DIAGNOS. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vitalhub 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 DIAGNOS 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation & earnings, VHI or ADK?

Vitalhub has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vitalhub C$127.08M 3.63 C$3.35M C$0.12 60.75 DIAGNOS C$65.48K 730.17 -C$3.81M -C$0.04 N/A

Is VHI or ADK more profitable?

Vitalhub has a net margin of 5.89% compared to DIAGNOS's net margin of -6,956.84%. DIAGNOS's return on equity of 11,659.44% beat Vitalhub's return on equity. Company Net Margins Return on Equity Return on Assets Vitalhub 5.89% 2.79% 3.81% DIAGNOS -6,956.84% 11,659.44% -134.33%

Do analysts prefer RHT or VHI?

Vitalhub has a consensus target price of C$12.67, indicating a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher probable upside, analysts plainly believe Vitalhub is more favorable than Reliq Health Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Reliq Health Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Vitalhub 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00

Do analysts recommend VHI or DOC?

Vitalhub presently has a consensus price target of C$12.67, indicating a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher probable upside, equities research analysts clearly believe Vitalhub is more favorable than CloudMD Software & Services. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vitalhub 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 CloudMD Software & Services 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate VHI or ZMD?

Vitalhub currently has a consensus target price of C$12.67, suggesting a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher probable upside, research analysts clearly believe Vitalhub is more favorable than ZoomMed. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vitalhub 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00 ZoomMed 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, VHI or ZMD?

Vitalhub has higher revenue and earnings than ZoomMed. ZoomMed is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Vitalhub C$127.08M 3.63 C$3.35M C$0.12 60.75 ZoomMed C$10K 203.39 -C$1.49M -C$0.01 N/A

Is VHI or ZMD more profitable?

Vitalhub has a net margin of 5.89% compared to ZoomMed's net margin of 0.00%. Vitalhub's return on equity of 2.79% beat ZoomMed's return on equity. Company Net Margins Return on Equity Return on Assets Vitalhub 5.89% 2.79% 3.81% ZoomMed N/A N/A N/A

Vitalhub (VHI) Competitors

C$7.29 -0.38 (-4.95%)

As of 10/14/2026 04:00 PM Eastern

Compare

VHI vs. CARE, ADK, RHT, DOC, and ZMD

Should you buy Vitalhub stock or one of its competitors? Vitalhub's main competitors and comparable companies include Dialogue Health Technologies (CARE), DIAGNOS (ADK), Reliq Health Technologies (RHT), CloudMD Software & Services (DOC), and ZoomMed (ZMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Vitalhub compare to Dialogue Health Technologies?

Vitalhub (TSE:VHI) and Dialogue Health Technologies (TSE:CARE) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Vitalhub has a beta of 1.40456, meaning that its share price is 40% more volatile than the broader market. Comparatively, Dialogue Health Technologies has a beta of 2.66, meaning that its share price is 166% more volatile than the broader market.

25.9% of Vitalhub shares are owned by institutional investors. Comparatively, 47.0% of Dialogue Health Technologies shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by company insiders. Comparatively, 11.7% of Dialogue Health Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Vitalhub has a net margin of 5.89% compared to Dialogue Health Technologies' net margin of -19.73%. Vitalhub's return on equity of 2.79% beat Dialogue Health Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vitalhub	5.89%	2.79%	3.81%
Dialogue Health Technologies	-19.73%	-19.76%	-10.01%

Vitalhub has higher revenue and earnings than Dialogue Health Technologies. Dialogue Health Technologies is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vitalhub	C$127.08M	3.63	C$3.35M	C$0.12	60.75
Dialogue Health Technologies	C$95.88M	0.00	-C$19.50M	-C$0.30	N/A

In the previous week, Vitalhub's average media sentiment score of 0.00 equaled Dialogue Health Technologies'average media sentiment score.

Company	Overall Sentiment
Vitalhub	Neutral
Dialogue Health Technologies	Neutral

Vitalhub presently has a consensus price target of C$12.67, suggesting a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher possible upside, equities analysts plainly believe Vitalhub is more favorable than Dialogue Health Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vitalhub	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
Dialogue Health Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Vitalhub beats Dialogue Health Technologies on 11 of the 13 factors compared between the two stocks.

How does Vitalhub compare to DIAGNOS?

Vitalhub (TSE:VHI) and DIAGNOS (CVE:ADK) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, dividends, analyst recommendations, earnings, risk, profitability and valuation.

25.9% of Vitalhub shares are owned by institutional investors. Comparatively, 0.3% of DIAGNOS shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by company insiders. Comparatively, 16.8% of DIAGNOS shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Vitalhub has higher revenue and earnings than DIAGNOS. DIAGNOS is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vitalhub	C$127.08M	3.63	C$3.35M	C$0.12	60.75
DIAGNOS	C$65.48K	730.17	-C$3.81M	-C$0.04	N/A

Vitalhub presently has a consensus price target of C$12.67, indicating a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher probable upside, equities research analysts clearly believe Vitalhub is more favorable than DIAGNOS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vitalhub	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
DIAGNOS	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Vitalhub has a net margin of 5.89% compared to DIAGNOS's net margin of -6,956.84%. DIAGNOS's return on equity of 11,659.44% beat Vitalhub's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vitalhub	5.89%	2.79%	3.81%
DIAGNOS	-6,956.84%	11,659.44%	-134.33%

In the previous week, Vitalhub's average media sentiment score of 0.00 equaled DIAGNOS'saverage media sentiment score.

Company	Overall Sentiment
Vitalhub	Neutral
DIAGNOS	Neutral

Vitalhub has a beta of 1.40456, indicating that its share price is 40% more volatile than the broader market. Comparatively, DIAGNOS has a beta of 0.400575, indicating that its share price is 60% less volatile than the broader market.

Summary

Vitalhub beats DIAGNOS on 12 of the 14 factors compared between the two stocks.

How does Vitalhub compare to Reliq Health Technologies?

Reliq Health Technologies (CVE:RHT) and Vitalhub (TSE:VHI) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Vitalhub has a consensus target price of C$12.67, indicating a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher probable upside, analysts plainly believe Vitalhub is more favorable than Reliq Health Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Reliq Health Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Vitalhub	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Reliq Health Technologies has a beta of 1.64, meaning that its share price is 64% more volatile than the broader market. Comparatively, Vitalhub has a beta of 1.40456, meaning that its share price is 40% more volatile than the broader market.

In the previous week, Reliq Health Technologies' average media sentiment score of 0.00 equaled Vitalhub'saverage media sentiment score.

Company	Overall Sentiment
Reliq Health Technologies	Neutral
Vitalhub	Neutral

Vitalhub has higher revenue and earnings than Reliq Health Technologies. Reliq Health Technologies is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Reliq Health Technologies	N/A	N/A	N/A	-C$0.02	N/A
Vitalhub	C$127.08M	3.63	C$3.35M	C$0.12	60.75

2.8% of Reliq Health Technologies shares are owned by institutional investors. Comparatively, 25.9% of Vitalhub shares are owned by institutional investors. 1.8% of Reliq Health Technologies shares are owned by insiders. Comparatively, 18.6% of Vitalhub shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Vitalhub has a net margin of 5.89% compared to Reliq Health Technologies' net margin of -95.54%. Vitalhub's return on equity of 2.79% beat Reliq Health Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Reliq Health Technologies	-95.54%	-221.64%	-5.30%
Vitalhub	5.89%	2.79%	3.81%

Summary

Vitalhub beats Reliq Health Technologies on 11 of the 12 factors compared between the two stocks.

How does Vitalhub compare to CloudMD Software & Services?

Vitalhub (TSE:VHI) and CloudMD Software & Services (CVE:DOC) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Vitalhub has a net margin of 5.89% compared to CloudMD Software & Services' net margin of -91.12%. Vitalhub's return on equity of 2.79% beat CloudMD Software & Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vitalhub	5.89%	2.79%	3.81%
CloudMD Software & Services	-91.12%	-102.91%	-8.74%

In the previous week, Vitalhub's average media sentiment score of 0.00 equaled CloudMD Software & Services'average media sentiment score.

Company	Overall Sentiment
Vitalhub	Neutral
CloudMD Software & Services	Neutral

Vitalhub has higher revenue and earnings than CloudMD Software & Services. CloudMD Software & Services is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vitalhub	C$127.08M	3.63	C$3.35M	C$0.12	60.75
CloudMD Software & Services	C$90.91M	0.12	-C$76.56M	-C$0.23	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vitalhub	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
CloudMD Software & Services	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Vitalhub has a beta of 1.40456, suggesting that its share price is 40% more volatile than the broader market. Comparatively, CloudMD Software & Services has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

25.9% of Vitalhub shares are owned by institutional investors. Comparatively, 0.5% of CloudMD Software & Services shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by insiders. Comparatively, 0.1% of CloudMD Software & Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Vitalhub beats CloudMD Software & Services on 14 of the 14 factors compared between the two stocks.

How does Vitalhub compare to ZoomMed?

Vitalhub (TSE:VHI) and ZoomMed (CVE:ZMD) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, profitability, media sentiment, earnings, analyst recommendations and dividends.

25.9% of Vitalhub shares are owned by institutional investors. 18.6% of Vitalhub shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Vitalhub has a net margin of 5.89% compared to ZoomMed's net margin of 0.00%. Vitalhub's return on equity of 2.79% beat ZoomMed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vitalhub	5.89%	2.79%	3.81%
ZoomMed	N/A	N/A	N/A

In the previous week, Vitalhub's average media sentiment score of 0.00 equaled ZoomMed'saverage media sentiment score.

Company	Overall Sentiment
Vitalhub	Neutral
ZoomMed	Neutral

Vitalhub has higher revenue and earnings than ZoomMed. ZoomMed is trading at a lower price-to-earnings ratio than Vitalhub, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vitalhub	C$127.08M	3.63	C$3.35M	C$0.12	60.75
ZoomMed	C$10K	203.39	-C$1.49M	-C$0.01	N/A

Vitalhub currently has a consensus target price of C$12.67, suggesting a potential upside of 73.75%. Given Vitalhub's stronger consensus rating and higher probable upside, research analysts clearly believe Vitalhub is more favorable than ZoomMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vitalhub	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00
ZoomMed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Vitalhub beats ZoomMed on 12 of the 13 factors compared between the two stocks.

Get Vitalhub News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VHI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VHI vs. The Competition

Export

Metric	Vitalhub	Healthcare Technology Industry	Healthcare Sector	TSE Exchange
Market Cap	C$461.74M	C$1.90B	C$7.19B	C$12.85B
Dividend Yield	N/A	3.94%	2.52%	6.33%
P/E Ratio	60.75	19.04	221.68	37.34
Price / Sales	3.63	91.85	546.08	8.34
Price / Cash	N/A	32.17	76.68	82.29
Price / Book	1.68	5.88	10.41	4.34
Net Income	C$3.35M	-C$19.09M	C$3.50B	C$299.09M
7 Day Performance	1.67%	-1.09%	-3.49%	-0.72%
1 Month Performance	-2.54%	-2.45%	-7.76%	-2.17%
1 Year Performance	-31.87%	-21.65%	0.83%	13.30%

Vitalhub Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VHI Vitalhub	1.8056 of 5 stars	C$7.29 -5.0%	C$12.67 +73.8%	-31.4%	C$461.74M	C$127.08M	60.75	700
CARE Dialogue Health Technologies	N/A	N/A	N/A	N/A	C$345.36M	C$95.88M	N/A	730
ADK DIAGNOS	N/A	C$0.47 -1.1%	N/A	+5.3%	C$56.89M	C$65.48K	N/A	16	Gap Up
RHT Reliq Health Technologies	N/A	C$0.22 flat	N/A	+0.0%	C$46.65M	N/A	N/A	12,600
DOC CloudMD Software & Services	N/A	C$0.04 flat	N/A	+0.0%	C$10.66M	C$90.91M	N/A	200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:VHI) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Vitalhub (VHI) Competitors

VHI vs. CARE, ADK, RHT, DOC, and ZMD

How does Vitalhub compare to Dialogue Health Technologies?

Summary

How does Vitalhub compare to DIAGNOS?

Summary

How does Vitalhub compare to Reliq Health Technologies?

Summary

How does Vitalhub compare to CloudMD Software & Services?

Summary

How does Vitalhub compare to ZoomMed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VHI vs. The Competition

Vitalhub Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Vitalhub (VHI) Competitors

VHI vs. CARE, ADK, RHT, DOC, and ZMD

How does Vitalhub compare to Dialogue Health Technologies?

Which has more risk and volatility, VHI or CARE?

Do institutionals and insiders have more ownership in VHI or CARE?

Is VHI or CARE more profitable?

Which has higher valuation & earnings, VHI or CARE?

Does the media refer more to VHI or CARE?

Do analysts rate VHI or CARE?

Summary

How does Vitalhub compare to DIAGNOS?

Do insiders & institutionals have more ownership in VHI or ADK?

Which has preferable valuation & earnings, VHI or ADK?

Do analysts prefer VHI or ADK?

Is VHI or ADK more profitable?

Does the media refer more to VHI or ADK?

Which has more volatility and risk, VHI or ADK?

Summary

How does Vitalhub compare to Reliq Health Technologies?

Do analysts prefer RHT or VHI?

Which has more volatility and risk, RHT or VHI?

Does the media favor RHT or VHI?

Which has better valuation and earnings, RHT or VHI?

Do institutionals and insiders believe in RHT or VHI?

Is RHT or VHI more profitable?

Summary

How does Vitalhub compare to CloudMD Software & Services?

Is VHI or DOC more profitable?

Does the media refer more to VHI or DOC?

Which has better valuation & earnings, VHI or DOC?

Do analysts recommend VHI or DOC?

Which has more volatility & risk, VHI or DOC?

Do insiders and institutionals believe in VHI or DOC?

Summary

How does Vitalhub compare to ZoomMed?

Do insiders and institutionals hold more shares of VHI or ZMD?

Is VHI or ZMD more profitable?

Does the media prefer VHI or ZMD?

Which has preferable earnings & valuation, VHI or ZMD?

Do analysts rate VHI or ZMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

VHI vs. The Competition

Vitalhub Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools